Supplemental Guarantor Information (Details) (USD $) | 3 Months Ended | 9 Months Ended | |
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Oct. 15, 2014 | Sep. 30, 2013 | Dec. 31, 2013 |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' | ' |
Revenue | $327.50 | $310.80 | $969.90 | ' | $948.50 | ' |
Operating costs and expenses | 311.5 | 253.1 | 861.4 | ' | 824.8 | ' |
Operating income (loss) | 16 | 57.7 | 108.5 | ' | 123.7 | ' |
Interest expense (income), net | 35.8 | 46.7 | 116.8 | ' | 140 | ' |
Other (income) expense, net | -0.2 | -1.2 | 0.5 | ' | -1.4 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | -39 | 10.7 | 162.7 | ' | -23 | ' |
Income tax expense (benefit) | -11.7 | 1.4 | 68.8 | ' | 3.6 | ' |
Net (loss) income | -27.3 | 9.3 | 93.9 | ' | -26.6 | ' |
Total comprehensive (loss) income | -26.1 | 34.1 | 97.5 | ' | 9.8 | ' |
Preferred stock dividends | 2.6 | 2.6 | 7.8 | ' | 7.8 | ' |
Net (loss) income applicable to common shareowners | -29.9 | 6.7 | 86.1 | ' | -34.4 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 181.5 | 413.7 | 181.5 | ' | 413.7 | ' |
Other current assets | 4.8 | ' | 4.8 | ' | ' | 1.6 |
Total current assets | 474.2 | ' | 474.2 | ' | ' | 251.1 |
Property, plant and equipment, net | 875.2 | ' | 875.2 | ' | ' | 902.8 |
Investment in CyrusOne | 284.7 | ' | 284.7 | ' | ' | 471 |
Other noncurrent assets | 33.8 | ' | 33.8 | ' | ' | 36.6 |
Total assets | 1,952.60 | ' | 1,952.60 | ' | ' | 2,107.30 |
Current portion of long-term debt | 11.9 | ' | 11.9 | ' | ' | 12.6 |
Accounts payable | 132.7 | ' | 132.7 | ' | ' | 89.4 |
Other current liabilities | 160.2 | ' | 160.2 | ' | ' | 36.8 |
Total current liabilities | 424.1 | ' | 424.1 | ' | ' | 254.3 |
Long-term debt, less current portion | 1,887 | ' | 1,887 | ' | ' | 2,252.60 |
Other noncurrent liabilities | 51.6 | ' | 51.6 | ' | ' | 74.4 |
Total liabilities | 2,537 | ' | 2,537 | ' | ' | 2,784 |
Shareowners' (deficit) equity | -584.4 | ' | -584.4 | ' | ' | -676.7 |
Total liabilities and shareowners' equity (deficit) | 1,952.60 | ' | 1,952.60 | ' | ' | 2,107.30 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 120.8 | ' | 59.8 | ' |
Capital expenditures | -45.6 | -46.1 | -121.1 | ' | -142 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 355.9 | ' | 0 | ' |
Dividends received from CyrusOne | 6 | ' | 22.4 | 28.4 | 14.2 | ' |
Proceeds from sale of assets | ' | ' | 2 | ' | 1.8 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | 0 | ' | -12.2 | ' |
Other investing activities | ' | ' | -5.7 | ' | 0 | ' |
Cash flows used in investing activities | ' | ' | 447.9 | ' | -137.8 | ' |
Proceeds from issuance of long-term debt | ' | ' | 0 | ' | 536 | ' |
Debt issuance costs | ' | ' | 0 | ' | -6.4 | ' |
Borrowings on revolving facilities, net | ' | ' | -33.8 | ' | -52 | ' |
Repayment of debt | ' | ' | -350.6 | ' | -6.7 | ' |
Proceeds from exercise of options and warrants | ' | ' | 1.2 | ' | 6.8 | ' |
Other financing activities | ' | ' | 0.9 | ' | 2.3 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -391.8 | ' | 468.1 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 176.9 | ' | 390.1 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 4.6 | 4.6 | 23.6 | ' |
Cash and cash equivalents at end of period | 181.5 | 413.7 | 181.5 | ' | 413.7 | ' |
Notes guaranteed by parent [Member] | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' | ' |
Revenue | 327.5 | 310.8 | 969.9 | ' | 948.5 | ' |
Operating costs and expenses | 311.5 | 253.1 | 861.4 | ' | 824.8 | ' |
Operating income (loss) | 16 | 57.7 | 108.5 | ' | 123.7 | ' |
Interest expense (income), net | 35.8 | 46.7 | 116.8 | ' | 140 | ' |
Other (income) expense, net | 19.2 | 0.3 | -171 | ' | 6.7 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | -39 | 10.7 | 162.7 | ' | -23 | ' |
Income tax expense (benefit) | -11.7 | 1.4 | 68.8 | ' | 3.6 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | ' | 0 | ' |
Net (loss) income | -27.3 | 9.3 | 93.9 | ' | -26.6 | ' |
Other comprehensive income (loss) | 1.2 | 24.8 | 3.6 | ' | 36.4 | ' |
Total comprehensive (loss) income | -26.1 | 34.1 | 97.5 | ' | 9.8 | ' |
Preferred stock dividends | 2.6 | 2.6 | 7.8 | ' | 7.8 | ' |
Net (loss) income applicable to common shareowners | -29.9 | 6.7 | 86.1 | ' | -34.4 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 181.5 | 413.7 | 181.5 | ' | 413.7 | ' |
Receivables, net | 182.1 | ' | 182.1 | ' | ' | 154.8 |
Other current assets | 110.6 | ' | 110.6 | ' | ' | 91.7 |
Total current assets | 474.2 | ' | 474.2 | ' | ' | 251.1 |
Property, plant and equipment, net | 875.2 | ' | 875.2 | ' | ' | 902.8 |
Investment in CyrusOne | 284.7 | ' | 284.7 | ' | ' | 471 |
Goodwill and intangibles, net | 16 | ' | 16 | ' | ' | 106.1 |
Investments in and advances to subsidiaries | 0 | ' | 0 | ' | ' | 0 |
Other noncurrent assets | 302.5 | ' | 302.5 | ' | ' | 376.3 |
Total assets | 1,952.60 | ' | 1,952.60 | ' | ' | 2,107.30 |
Current portion of long-term debt | 11.9 | ' | 11.9 | ' | ' | 12.6 |
Accounts payable | 134 | ' | 134 | ' | ' | 89.9 |
Other current liabilities | 278.2 | ' | 278.2 | ' | ' | 151.8 |
Total current liabilities | 424.1 | ' | 424.1 | ' | ' | 254.3 |
Long-term debt, less current portion | 1,887 | ' | 1,887 | ' | ' | 2,252.60 |
Other noncurrent liabilities | 225.9 | ' | 225.9 | ' | ' | 277.1 |
Intercompany payables | 0 | ' | 0 | ' | ' | 0 |
Total liabilities | 2,537 | ' | 2,537 | ' | ' | 2,784 |
Shareowners' (deficit) equity | -584.4 | ' | -584.4 | ' | ' | -676.7 |
Total liabilities and shareowners' equity (deficit) | 1,952.60 | ' | 1,952.60 | ' | ' | 2,107.30 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 120.8 | ' | 59.8 | ' |
Capital expenditures | ' | ' | -121.1 | ' | -142 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 355.9 | ' | ' | ' |
Dividends received from CyrusOne | ' | ' | 22.4 | ' | 14.2 | ' |
Proceeds from sale of assets | ' | ' | 196.4 | ' | 1.8 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | ' | -12.2 | ' |
Other investing activities | ' | ' | -5.7 | ' | 0.4 | ' |
Cash flows used in investing activities | ' | ' | 447.9 | ' | -137.8 | ' |
Proceeds from issuance of long-term debt | ' | ' | ' | ' | 536 | ' |
Funding between Parent and subsidiaries, net | ' | ' | 0 | ' | 0 | ' |
Debt issuance costs | ' | ' | ' | ' | -6.4 | ' |
Borrowings on revolving facilities, net | ' | ' | -33.8 | ' | -52 | ' |
Repayment of debt | ' | ' | -350.6 | ' | -6.7 | ' |
Proceeds from exercise of options and warrants | ' | ' | 1.2 | ' | 6.8 | ' |
Other financing activities | ' | ' | -8.6 | ' | -9.6 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -391.8 | ' | 468.1 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 176.9 | ' | 390.1 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 4.6 | 4.6 | 23.6 | ' |
Cash and cash equivalents at end of period | 181.5 | 413.7 | 181.5 | ' | 413.7 | ' |
Notes guaranteed by parent [Member] | Parent Company [Member] | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' | ' |
Revenue | 0 | 0 | 0 | ' | 0 | ' |
Operating costs and expenses | 2.9 | 1.5 | 13.8 | ' | 51.2 | ' |
Operating income (loss) | -2.9 | -1.5 | -13.8 | ' | -51.2 | ' |
Interest expense (income), net | 34.8 | 42.9 | 109.8 | ' | 125 | ' |
Other (income) expense, net | 18.9 | -0.4 | 18.2 | ' | -1.1 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | -56.6 | -44 | -141.8 | ' | -175.1 | ' |
Income tax expense (benefit) | -18.1 | -18.5 | -40.6 | ' | -59.8 | ' |
Equity in earnings of subsidiaries, net of tax | 11.2 | 34.8 | 195.1 | ' | 88.7 | ' |
Net (loss) income | -27.3 | 9.3 | 93.9 | ' | -26.6 | ' |
Other comprehensive income (loss) | 1.2 | 24.8 | 3.6 | ' | 36.5 | ' |
Total comprehensive (loss) income | -26.1 | 34.1 | 97.5 | ' | 9.9 | ' |
Preferred stock dividends | 2.6 | 2.6 | 7.8 | ' | 7.8 | ' |
Net (loss) income applicable to common shareowners | -29.9 | 6.7 | 86.1 | ' | -34.4 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 179.1 | 411.1 | 179.1 | ' | 411.1 | ' |
Receivables, net | 2 | ' | 2 | ' | ' | 2.6 |
Other current assets | 3.4 | ' | 3.4 | ' | ' | 4.4 |
Total current assets | 184.5 | ' | 184.5 | ' | ' | 9.1 |
Property, plant and equipment, net | 0.1 | ' | 0.1 | ' | ' | 0.1 |
Investment in CyrusOne | 0 | ' | 0 | ' | ' | 0 |
Goodwill and intangibles, net | 0 | ' | 0 | ' | ' | 0 |
Investments in and advances to subsidiaries | 1,081.70 | ' | 1,081.70 | ' | ' | 1,406.60 |
Other noncurrent assets | 271.3 | ' | 271.3 | ' | ' | 359.1 |
Total assets | 1,537.60 | ' | 1,537.60 | ' | ' | 1,774.90 |
Current portion of long-term debt | 5.4 | ' | 5.4 | ' | ' | 5.4 |
Accounts payable | 1.1 | ' | 1.1 | ' | ' | 1.5 |
Other current liabilities | 66.8 | ' | 66.8 | ' | ' | 67.7 |
Total current liabilities | 73.3 | ' | 73.3 | ' | ' | 74.6 |
Long-term debt, less current portion | 1,550 | ' | 1,550 | ' | ' | 1,916.10 |
Other noncurrent liabilities | 186.4 | ' | 186.4 | ' | ' | 214.5 |
Intercompany payables | 312.3 | ' | 312.3 | ' | ' | 246.4 |
Total liabilities | 2,122 | ' | 2,122 | ' | ' | 2,451.60 |
Shareowners' (deficit) equity | -584.4 | ' | -584.4 | ' | ' | -676.7 |
Total liabilities and shareowners' equity (deficit) | 1,537.60 | ' | 1,537.60 | ' | ' | 1,774.90 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | -17.9 | ' | -165 | ' |
Capital expenditures | ' | ' | 0 | ' | 0 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 0 | ' | ' | ' |
Dividends received from CyrusOne | ' | ' | 0 | ' | 0 | ' |
Proceeds from sale of assets | ' | ' | 0 | ' | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | ' | 0 | ' |
Other investing activities | ' | ' | -0.2 | ' | 0 | ' |
Cash flows used in investing activities | ' | ' | -0.2 | ' | 0 | ' |
Proceeds from issuance of long-term debt | ' | ' | ' | ' | 536 | ' |
Funding between Parent and subsidiaries, net | ' | ' | 586.1 | ' | 45.5 | ' |
Debt issuance costs | ' | ' | ' | ' | -6.4 | ' |
Borrowings on revolving facilities, net | ' | ' | -40 | ' | 0 | ' |
Repayment of debt | ' | ' | -343.3 | ' | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | 1.2 | ' | 6.8 | ' |
Other financing activities | ' | ' | -8.9 | ' | -9.6 | ' |
Cash flows provided by (used in) financing activities | ' | ' | 195.1 | ' | 572.3 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 177 | ' | 407.3 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 2.1 | 2.1 | 3.8 | ' |
Cash and cash equivalents at end of period | 179.1 | 411.1 | 179.1 | ' | 411.1 | ' |
Notes guaranteed by parent [Member] | Cincinnati Bell Telephone Company [Member] | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' | ' |
Revenue | 163.8 | 161.4 | 491.4 | ' | 482.3 | ' |
Operating costs and expenses | 121.2 | 115.3 | 349.8 | ' | 340 | ' |
Operating income (loss) | 42.6 | 46.1 | 141.6 | ' | 142.3 | ' |
Interest expense (income), net | -1.3 | -0.3 | -3.1 | ' | -1.4 | ' |
Other (income) expense, net | 1.6 | 1.8 | 5.5 | ' | 4.4 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | 42.3 | 44.6 | 139.2 | ' | 139.3 | ' |
Income tax expense (benefit) | 15.4 | 16.4 | 50.8 | ' | 51.2 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | ' | 0 | ' |
Net (loss) income | 26.9 | 28.2 | 88.4 | ' | 88.1 | ' |
Other comprehensive income (loss) | 0 | 0 | 0 | ' | 0 | ' |
Total comprehensive (loss) income | 26.9 | 28.2 | 88.4 | ' | 88.1 | ' |
Preferred stock dividends | 0 | 0 | 0 | ' | 0 | ' |
Net (loss) income applicable to common shareowners | 26.9 | 28.2 | 88.4 | ' | 88.1 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 1.5 | 2 | 1.5 | ' | 2 | ' |
Receivables, net | 0 | ' | 0 | ' | ' | 0 |
Other current assets | 24.8 | ' | 24.8 | ' | ' | 24.1 |
Total current assets | 26.3 | ' | 26.3 | ' | ' | 25.9 |
Property, plant and equipment, net | 752.1 | ' | 752.1 | ' | ' | 706.5 |
Investment in CyrusOne | 0 | ' | 0 | ' | ' | 0 |
Goodwill and intangibles, net | 2.2 | ' | 2.2 | ' | ' | 2.3 |
Investments in and advances to subsidiaries | 314.1 | ' | 314.1 | ' | ' | 247.7 |
Other noncurrent assets | 5.2 | ' | 5.2 | ' | ' | 6.1 |
Total assets | 1,099.90 | ' | 1,099.90 | ' | ' | 988.5 |
Current portion of long-term debt | 3.3 | ' | 3.3 | ' | ' | 3.9 |
Accounts payable | 78.3 | ' | 78.3 | ' | ' | 45.9 |
Other current liabilities | 47 | ' | 47 | ' | ' | 49.4 |
Total current liabilities | 128.6 | ' | 128.6 | ' | ' | 99.2 |
Long-term debt, less current portion | 139.8 | ' | 139.8 | ' | ' | 141.8 |
Other noncurrent liabilities | 167.8 | ' | 167.8 | ' | ' | 172.2 |
Intercompany payables | 0 | ' | 0 | ' | ' | 0 |
Total liabilities | 436.2 | ' | 436.2 | ' | ' | 413.2 |
Shareowners' (deficit) equity | 663.7 | ' | 663.7 | ' | ' | 575.3 |
Total liabilities and shareowners' equity (deficit) | 1,099.90 | ' | 1,099.90 | ' | ' | 988.5 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 165.2 | ' | 170.1 | ' |
Capital expenditures | ' | ' | -96.5 | ' | -108.7 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 0 | ' | ' | ' |
Dividends received from CyrusOne | ' | ' | 0 | ' | 0 | ' |
Proceeds from sale of assets | ' | ' | 0.2 | ' | 1.8 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | ' | 0 | ' |
Other investing activities | ' | ' | 0 | ' | 0 | ' |
Cash flows used in investing activities | ' | ' | -96.3 | ' | -106.9 | ' |
Proceeds from issuance of long-term debt | ' | ' | ' | ' | 0 | ' |
Funding between Parent and subsidiaries, net | ' | ' | -66.5 | ' | -60.5 | ' |
Debt issuance costs | ' | ' | ' | ' | 0 | ' |
Borrowings on revolving facilities, net | ' | ' | 0 | ' | 0 | ' |
Repayment of debt | ' | ' | -3 | ' | -2.6 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | ' | 0 | ' |
Other financing activities | ' | ' | 0.3 | ' | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -69.2 | ' | -63.1 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | -0.3 | ' | 0.1 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 1.8 | 1.8 | 1.9 | ' |
Cash and cash equivalents at end of period | 1.5 | 2 | 1.5 | ' | 2 | ' |
Notes guaranteed by parent [Member] | Non-Guarantor Subsidiaries [Member] | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' | ' |
Revenue | 176.9 | 163.5 | 520.5 | ' | 508.4 | ' |
Operating costs and expenses | 200.6 | 150.4 | 539.8 | ' | 475.8 | ' |
Operating income (loss) | -23.7 | 13.1 | -19.3 | ' | 32.6 | ' |
Interest expense (income), net | 2.3 | 4.1 | 10.1 | ' | 16.4 | ' |
Other (income) expense, net | -1.3 | -1.1 | -194.7 | ' | 3.4 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | -24.7 | 10.1 | 165.3 | ' | 12.8 | ' |
Income tax expense (benefit) | -9 | 3.5 | 58.6 | ' | 12.2 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | ' | 0 | ' |
Net (loss) income | -15.7 | 6.6 | 106.7 | ' | 0.6 | ' |
Other comprehensive income (loss) | 0 | 0 | 0 | ' | -0.1 | ' |
Total comprehensive (loss) income | -15.7 | 6.6 | 106.7 | ' | 0.5 | ' |
Preferred stock dividends | 0 | 0 | 0 | ' | 0 | ' |
Net (loss) income applicable to common shareowners | -15.7 | 6.6 | 106.7 | ' | 0.6 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 0.9 | 0.6 | 0.9 | ' | 0.6 | ' |
Receivables, net | 180.1 | ' | 180.1 | ' | ' | 152.2 |
Other current assets | 83.1 | ' | 83.1 | ' | ' | 63.9 |
Total current assets | 264.1 | ' | 264.1 | ' | ' | 216.8 |
Property, plant and equipment, net | 123 | ' | 123 | ' | ' | 196.2 |
Investment in CyrusOne | 284.7 | ' | 284.7 | ' | ' | 471 |
Goodwill and intangibles, net | 13.8 | ' | 13.8 | ' | ' | 103.8 |
Investments in and advances to subsidiaries | 311.2 | ' | 311.2 | ' | ' | 0 |
Other noncurrent assets | 182.1 | ' | 182.1 | ' | ' | 178.9 |
Total assets | 1,178.90 | ' | 1,178.90 | ' | ' | 1,166.70 |
Current portion of long-term debt | 3.2 | ' | 3.2 | ' | ' | 3.3 |
Accounts payable | 54.6 | ' | 54.6 | ' | ' | 42.5 |
Other current liabilities | 164.3 | ' | 164.3 | ' | ' | 34.6 |
Total current liabilities | 222.1 | ' | 222.1 | ' | ' | 80.4 |
Long-term debt, less current portion | 197.2 | ' | 197.2 | ' | ' | 194.7 |
Other noncurrent liabilities | 28.6 | ' | 28.6 | ' | ' | 59 |
Intercompany payables | 0 | ' | 0 | ' | ' | 199.7 |
Total liabilities | 447.9 | ' | 447.9 | ' | ' | 533.8 |
Shareowners' (deficit) equity | 731 | ' | 731 | ' | ' | 632.9 |
Total liabilities and shareowners' equity (deficit) | 1,178.90 | ' | 1,178.90 | ' | ' | 1,166.70 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | -26.5 | ' | 54.7 | ' |
Capital expenditures | ' | ' | -24.6 | ' | -33.3 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 355.9 | ' | ' | ' |
Dividends received from CyrusOne | ' | ' | 22.4 | ' | 14.2 | ' |
Proceeds from sale of assets | ' | ' | 196.2 | ' | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | ' | -12.2 | ' |
Other investing activities | ' | ' | -5.5 | ' | 0.4 | ' |
Cash flows used in investing activities | ' | ' | 544.4 | ' | -30.9 | ' |
Proceeds from issuance of long-term debt | ' | ' | ' | ' | 0 | ' |
Funding between Parent and subsidiaries, net | ' | ' | -519.6 | ' | 15 | ' |
Debt issuance costs | ' | ' | ' | ' | 0 | ' |
Borrowings on revolving facilities, net | ' | ' | 6.2 | ' | -52 | ' |
Repayment of debt | ' | ' | -4.3 | ' | -4.1 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | ' | 0 | ' |
Other financing activities | ' | ' | 0 | ' | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -517.7 | ' | -41.1 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 0.2 | ' | -17.3 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 0.7 | 0.7 | 17.9 | ' |
Cash and cash equivalents at end of period | 0.9 | 0.6 | 0.9 | ' | 0.6 | ' |
Notes guaranteed by parent [Member] | Consolidation, Eliminations [Member] | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' | ' |
Revenue | -13.2 | -14.1 | -42 | ' | -42.2 | ' |
Operating costs and expenses | -13.2 | -14.1 | -42 | ' | -42.2 | ' |
Operating income (loss) | 0 | 0 | 0 | ' | 0 | ' |
Interest expense (income), net | 0 | 0 | 0 | ' | 0 | ' |
Other (income) expense, net | 0 | 0 | 0 | ' | 0 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | 0 | 0 | 0 | ' | 0 | ' |
Income tax expense (benefit) | 0 | 0 | 0 | ' | 0 | ' |
Equity in earnings of subsidiaries, net of tax | -11.2 | -34.8 | -195.1 | ' | -88.7 | ' |
Net (loss) income | -11.2 | -34.8 | -195.1 | ' | -88.7 | ' |
Other comprehensive income (loss) | 0 | 0 | 0 | ' | 0 | ' |
Total comprehensive (loss) income | -11.2 | -34.8 | -195.1 | ' | -88.7 | ' |
Preferred stock dividends | 0 | 0 | 0 | ' | 0 | ' |
Net (loss) income applicable to common shareowners | -11.2 | -34.8 | -195.1 | ' | -88.7 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 0 | 0 | 0 | ' | 0 | ' |
Receivables, net | 0 | ' | 0 | ' | ' | 0 |
Other current assets | -0.7 | ' | -0.7 | ' | ' | -0.7 |
Total current assets | -0.7 | ' | -0.7 | ' | ' | -0.7 |
Property, plant and equipment, net | 0 | ' | 0 | ' | ' | 0 |
Investment in CyrusOne | 0 | ' | 0 | ' | ' | 0 |
Goodwill and intangibles, net | 0 | ' | 0 | ' | ' | 0 |
Investments in and advances to subsidiaries | -1,707 | ' | -1,707 | ' | ' | -1,654.30 |
Other noncurrent assets | -156.1 | ' | -156.1 | ' | ' | -167.8 |
Total assets | -1,863.80 | ' | -1,863.80 | ' | ' | -1,822.80 |
Current portion of long-term debt | 0 | ' | 0 | ' | ' | 0 |
Accounts payable | 0 | ' | 0 | ' | ' | 0 |
Other current liabilities | 0.1 | ' | 0.1 | ' | ' | 0.1 |
Total current liabilities | 0.1 | ' | 0.1 | ' | ' | 0.1 |
Long-term debt, less current portion | 0 | ' | 0 | ' | ' | 0 |
Other noncurrent liabilities | -156.9 | ' | -156.9 | ' | ' | -168.6 |
Intercompany payables | -312.3 | ' | -312.3 | ' | ' | -446.1 |
Total liabilities | -469.1 | ' | -469.1 | ' | ' | -614.6 |
Shareowners' (deficit) equity | -1,394.70 | ' | -1,394.70 | ' | ' | -1,208.20 |
Total liabilities and shareowners' equity (deficit) | -1,863.80 | ' | -1,863.80 | ' | ' | -1,822.80 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 0 | ' | 0 | ' |
Capital expenditures | ' | ' | 0 | ' | 0 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 0 | ' | ' | ' |
Dividends received from CyrusOne | ' | ' | 0 | ' | 0 | ' |
Proceeds from sale of assets | ' | ' | 0 | ' | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | ' | 0 | ' |
Other investing activities | ' | ' | 0 | ' | 0 | ' |
Cash flows used in investing activities | ' | ' | 0 | ' | 0 | ' |
Proceeds from issuance of long-term debt | ' | ' | ' | ' | 0 | ' |
Funding between Parent and subsidiaries, net | ' | ' | 0 | ' | 0 | ' |
Debt issuance costs | ' | ' | ' | ' | 0 | ' |
Borrowings on revolving facilities, net | ' | ' | 0 | ' | 0 | ' |
Repayment of debt | ' | ' | 0 | ' | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | ' | 0 | ' |
Other financing activities | ' | ' | 0 | ' | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | 0 | ' | 0 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 0 | ' | 0 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 0 | 0 | 0 | ' |
Cash and cash equivalents at end of period | 0 | 0 | 0 | ' | 0 | ' |
Notes guaranteed by subsidiaries [Member] | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' | ' |
Revenue | 327.5 | 310.8 | 969.9 | ' | 948.5 | ' |
Operating costs and expenses | 311.5 | 253.1 | 861.4 | ' | 824.8 | ' |
Operating income (loss) | 16 | 57.7 | 108.5 | ' | 123.7 | ' |
Interest expense (income), net | 35.8 | 46.7 | 116.8 | ' | 140 | ' |
Other (income) expense, net | 19.2 | 0.3 | -171 | ' | 6.7 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | -39 | 10.7 | 162.7 | ' | -23 | ' |
Income tax expense (benefit) | -11.7 | 1.4 | 68.8 | ' | 3.6 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | ' | 0 | ' |
Net (loss) income | -27.3 | 9.3 | 93.9 | ' | -26.6 | ' |
Other comprehensive income (loss) | 1.2 | 24.8 | 3.6 | ' | 36.4 | ' |
Total comprehensive (loss) income | -26.1 | 34.1 | 97.5 | ' | 9.8 | ' |
Preferred stock dividends | 2.6 | 2.6 | 7.8 | ' | 7.8 | ' |
Net (loss) income applicable to common shareowners | -29.9 | 6.7 | 86.1 | ' | -34.4 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 181.5 | 413.7 | 181.5 | ' | 413.7 | ' |
Receivables, net | 182.1 | ' | 182.1 | ' | ' | 154.8 |
Other current assets | 110.6 | ' | 110.6 | ' | ' | 91.7 |
Total current assets | 474.2 | ' | 474.2 | ' | ' | 251.1 |
Property, plant and equipment, net | 875.2 | ' | 875.2 | ' | ' | 902.8 |
Investment in CyrusOne | 284.7 | ' | 284.7 | ' | ' | 471 |
Goodwill and intangibles, net | 16 | ' | 16 | ' | ' | 106.1 |
Investments in and advances to subsidiaries | 0 | ' | 0 | ' | ' | 0 |
Other noncurrent assets | 302.5 | ' | 302.5 | ' | ' | 376.3 |
Total assets | 1,952.60 | ' | 1,952.60 | ' | ' | 2,107.30 |
Current portion of long-term debt | 11.9 | ' | 11.9 | ' | ' | 12.6 |
Accounts payable | 134 | ' | 134 | ' | ' | 89.9 |
Other current liabilities | 278.2 | ' | 278.2 | ' | ' | 151.8 |
Total current liabilities | 424.1 | ' | 424.1 | ' | ' | 254.3 |
Long-term debt, less current portion | 1,887 | ' | 1,887 | ' | ' | 2,252.60 |
Other noncurrent liabilities | 225.9 | ' | 225.9 | ' | ' | 277.1 |
Intercompany payables | 0 | ' | 0 | ' | ' | 0 |
Total liabilities | 2,537 | ' | 2,537 | ' | ' | 2,784 |
Shareowners' (deficit) equity | -584.4 | ' | -584.4 | ' | ' | -676.7 |
Total liabilities and shareowners' equity (deficit) | 1,952.60 | ' | 1,952.60 | ' | ' | 2,107.30 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 120.8 | ' | 59.8 | ' |
Capital expenditures | ' | ' | -121.1 | ' | -142 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 355.9 | ' | ' | ' |
Dividends received from CyrusOne | ' | ' | 22.4 | ' | 14.2 | ' |
Proceeds from sale of assets | ' | ' | 196.4 | ' | 1.8 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | ' | -12.2 | ' |
Other investing activities | ' | ' | -5.7 | ' | 0.4 | ' |
Cash flows used in investing activities | ' | ' | 447.9 | ' | -137.8 | ' |
Proceeds from issuance of long-term debt | ' | ' | ' | ' | 536 | ' |
Funding between Parent and subsidiaries, net | ' | ' | 0 | ' | 0 | ' |
Debt issuance costs | ' | ' | ' | ' | -6.4 | ' |
Borrowings on revolving facilities, net | ' | ' | -33.8 | ' | -52 | ' |
Repayment of debt | ' | ' | -350.6 | ' | -6.7 | ' |
Proceeds from exercise of options and warrants | ' | ' | 1.2 | ' | 6.8 | ' |
Other financing activities | ' | ' | -8.6 | ' | -9.6 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -391.8 | ' | 468.1 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 176.9 | ' | 390.1 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 4.6 | 4.6 | 23.6 | ' |
Cash and cash equivalents at end of period | 181.5 | 413.7 | 181.5 | ' | 413.7 | ' |
Notes guaranteed by subsidiaries [Member] | Parent Company [Member] | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' | ' |
Revenue | 0 | 0 | 0 | ' | 0 | ' |
Operating costs and expenses | 2.9 | 1.5 | 13.8 | ' | 51.2 | ' |
Operating income (loss) | -2.9 | -1.5 | -13.8 | ' | -51.2 | ' |
Interest expense (income), net | 34.8 | 42.9 | 109.8 | ' | 125 | ' |
Other (income) expense, net | 18.9 | -0.4 | 18.2 | ' | -1.1 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | -56.6 | -44 | -141.8 | ' | -175.1 | ' |
Income tax expense (benefit) | -18.1 | -18.5 | -40.6 | ' | -59.8 | ' |
Equity in earnings of subsidiaries, net of tax | 11.2 | 34.8 | 195.1 | ' | 88.7 | ' |
Net (loss) income | -27.3 | 9.3 | 93.9 | ' | -26.6 | ' |
Other comprehensive income (loss) | 1.2 | 24.8 | 3.6 | ' | 36.5 | ' |
Total comprehensive (loss) income | -26.1 | 34.1 | 97.5 | ' | 9.9 | ' |
Preferred stock dividends | 2.6 | 2.6 | 7.8 | ' | 7.8 | ' |
Net (loss) income applicable to common shareowners | -29.9 | 6.7 | 86.1 | ' | -34.4 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 179.1 | 411.1 | 179.1 | ' | 411.1 | ' |
Receivables, net | 2 | ' | 2 | ' | ' | 2.6 |
Other current assets | 3.4 | ' | 3.4 | ' | ' | 4.4 |
Total current assets | 184.5 | ' | 184.5 | ' | ' | 9.1 |
Property, plant and equipment, net | 0.1 | ' | 0.1 | ' | ' | 0.1 |
Investment in CyrusOne | 0 | ' | 0 | ' | ' | 0 |
Goodwill and intangibles, net | 0 | ' | 0 | ' | ' | 0 |
Investments in and advances to subsidiaries | 1,081.70 | ' | 1,081.70 | ' | ' | 1,406.60 |
Other noncurrent assets | 271.3 | ' | 271.3 | ' | ' | 359.1 |
Total assets | 1,537.60 | ' | 1,537.60 | ' | ' | 1,774.90 |
Current portion of long-term debt | 5.4 | ' | 5.4 | ' | ' | 5.4 |
Accounts payable | 1.1 | ' | 1.1 | ' | ' | 1.5 |
Other current liabilities | 66.8 | ' | 66.8 | ' | ' | 67.7 |
Total current liabilities | 73.3 | ' | 73.3 | ' | ' | 74.6 |
Long-term debt, less current portion | 1,550 | ' | 1,550 | ' | ' | 1,916.10 |
Other noncurrent liabilities | 186.4 | ' | 186.4 | ' | ' | 214.5 |
Intercompany payables | 312.3 | ' | 312.3 | ' | ' | 246.4 |
Total liabilities | 2,122 | ' | 2,122 | ' | ' | 2,451.60 |
Shareowners' (deficit) equity | -584.4 | ' | -584.4 | ' | ' | -676.7 |
Total liabilities and shareowners' equity (deficit) | 1,537.60 | ' | 1,537.60 | ' | ' | 1,774.90 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | -17.9 | ' | -165 | ' |
Capital expenditures | ' | ' | 0 | ' | 0 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 0 | ' | ' | ' |
Dividends received from CyrusOne | ' | ' | 0 | ' | 0 | ' |
Proceeds from sale of assets | ' | ' | 0 | ' | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | ' | 0 | ' |
Other investing activities | ' | ' | -0.2 | ' | 0 | ' |
Cash flows used in investing activities | ' | ' | -0.2 | ' | 0 | ' |
Proceeds from issuance of long-term debt | ' | ' | ' | ' | 536 | ' |
Funding between Parent and subsidiaries, net | ' | ' | 586.1 | ' | 45.5 | ' |
Debt issuance costs | ' | ' | ' | ' | -6.4 | ' |
Borrowings on revolving facilities, net | ' | ' | -40 | ' | 0 | ' |
Repayment of debt | ' | ' | -343.3 | ' | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | 1.2 | ' | 6.8 | ' |
Other financing activities | ' | ' | -8.9 | ' | -9.6 | ' |
Cash flows provided by (used in) financing activities | ' | ' | 195.1 | ' | 572.3 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 177 | ' | 407.3 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 2.1 | 2.1 | 3.8 | ' |
Cash and cash equivalents at end of period | 179.1 | 411.1 | 179.1 | ' | 411.1 | ' |
Notes guaranteed by subsidiaries [Member] | Guarantor Subsidiaries [Member] | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' | ' |
Revenue | 190.2 | 177.4 | 560.5 | ' | 530.7 | ' |
Operating costs and expenses | 212.4 | 162.5 | 575.6 | ' | 496.1 | ' |
Operating income (loss) | -22.2 | 14.9 | -15.1 | ' | 34.6 | ' |
Interest expense (income), net | 1.9 | 3.5 | 8.9 | ' | 11.2 | ' |
Other (income) expense, net | 3.4 | 3.2 | -179.6 | ' | 12.1 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | -27.5 | 8.2 | 155.6 | ' | 11.3 | ' |
Income tax expense (benefit) | -10 | 3.1 | 55.1 | ' | 11.9 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | ' | 0.7 | ' |
Net (loss) income | -17.5 | 5.1 | 100.5 | ' | 0.1 | ' |
Other comprehensive income (loss) | 0 | 0 | 0 | ' | 0 | ' |
Total comprehensive (loss) income | -17.5 | 5.1 | 100.5 | ' | 0.1 | ' |
Preferred stock dividends | 0 | 0 | 0 | ' | 0 | ' |
Net (loss) income applicable to common shareowners | -17.5 | 5.1 | 100.5 | ' | 0.1 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 0.4 | 0.5 | 0.4 | ' | 0.5 | ' |
Receivables, net | 6 | ' | 6 | ' | ' | 7.2 |
Other current assets | 79.3 | ' | 79.3 | ' | ' | 60.7 |
Total current assets | 85.7 | ' | 85.7 | ' | ' | 68.2 |
Property, plant and equipment, net | 122.6 | ' | 122.6 | ' | ' | 194.1 |
Investment in CyrusOne | 284.7 | ' | 284.7 | ' | ' | 471 |
Goodwill and intangibles, net | 13.8 | ' | 13.8 | ' | ' | 103.8 |
Investments in and advances to subsidiaries | 370.3 | ' | 370.3 | ' | ' | -1.6 |
Other noncurrent assets | 183.1 | ' | 183.1 | ' | ' | 179.9 |
Total assets | 1,060.20 | ' | 1,060.20 | ' | ' | 1,015.40 |
Current portion of long-term debt | 3.2 | ' | 3.2 | ' | ' | 3 |
Accounts payable | 69.4 | ' | 69.4 | ' | ' | 72.3 |
Other current liabilities | 166.4 | ' | 166.4 | ' | ' | 36.9 |
Total current liabilities | 239 | ' | 239 | ' | ' | 112.2 |
Long-term debt, less current portion | 84.8 | ' | 84.8 | ' | ' | 87 |
Other noncurrent liabilities | 31 | ' | 31 | ' | ' | 61.3 |
Intercompany payables | 0 | ' | 0 | ' | ' | 149.9 |
Total liabilities | 354.8 | ' | 354.8 | ' | ' | 410.4 |
Shareowners' (deficit) equity | 705.4 | ' | 705.4 | ' | ' | 605 |
Total liabilities and shareowners' equity (deficit) | 1,060.20 | ' | 1,060.20 | ' | ' | 1,015.40 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | -18.6 | ' | 27.4 | ' |
Capital expenditures | ' | ' | -24.6 | ' | -25.6 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 355.9 | ' | ' | ' |
Dividends received from CyrusOne | ' | ' | 22.4 | ' | 14.2 | ' |
Proceeds from sale of assets | ' | ' | 194.4 | ' | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | ' | 0 | ' |
Other investing activities | ' | ' | -5.5 | ' | 0 | ' |
Cash flows used in investing activities | ' | ' | 542.6 | ' | -11.4 | ' |
Proceeds from issuance of long-term debt | ' | ' | ' | ' | 0 | ' |
Funding between Parent and subsidiaries, net | ' | ' | -521.8 | ' | -12.6 | ' |
Debt issuance costs | ' | ' | ' | ' | 0 | ' |
Borrowings on revolving facilities, net | ' | ' | 0 | ' | 0 | ' |
Repayment of debt | ' | ' | -2.1 | ' | -3.2 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | ' | 0 | ' |
Other financing activities | ' | ' | 0 | ' | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -523.9 | ' | -15.8 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 0.1 | ' | 0.2 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 0.3 | 0.3 | 0.3 | ' |
Cash and cash equivalents at end of period | 0.4 | 0.5 | 0.4 | ' | 0.5 | ' |
Notes guaranteed by subsidiaries [Member] | Non-Guarantor Subsidiaries [Member] | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' | ' |
Revenue | 150.5 | 147.5 | 451.4 | ' | 460 | ' |
Operating costs and expenses | 109.4 | 103.2 | 314 | ' | 319.7 | ' |
Operating income (loss) | 41.1 | 44.3 | 137.4 | ' | 140.3 | ' |
Interest expense (income), net | -0.9 | 0.3 | -1.9 | ' | 3.8 | ' |
Other (income) expense, net | -3.1 | -2.5 | -9.6 | ' | -4.3 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | 45.1 | 46.5 | 148.9 | ' | 140.8 | ' |
Income tax expense (benefit) | 16.4 | 16.8 | 54.3 | ' | 51.5 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | ' | 0 | ' |
Net (loss) income | 28.7 | 29.7 | 94.6 | ' | 89.3 | ' |
Other comprehensive income (loss) | 0 | 0 | 0 | ' | -0.1 | ' |
Total comprehensive (loss) income | 28.7 | 29.7 | 94.6 | ' | 89.2 | ' |
Preferred stock dividends | 0 | 0 | 0 | ' | 0 | ' |
Net (loss) income applicable to common shareowners | 28.7 | 29.7 | 94.6 | ' | 89.3 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 2 | 2.1 | 2 | ' | 2.1 | ' |
Receivables, net | 174.1 | ' | 174.1 | ' | ' | 145 |
Other current assets | 28.6 | ' | 28.6 | ' | ' | 27.3 |
Total current assets | 204.7 | ' | 204.7 | ' | ' | 174.5 |
Property, plant and equipment, net | 752.5 | ' | 752.5 | ' | ' | 708.6 |
Investment in CyrusOne | 0 | ' | 0 | ' | ' | 0 |
Goodwill and intangibles, net | 2.2 | ' | 2.2 | ' | ' | 2.3 |
Investments in and advances to subsidiaries | 293.9 | ' | 293.9 | ' | ' | 218.2 |
Other noncurrent assets | 4.2 | ' | 4.2 | ' | ' | 5.1 |
Total assets | 1,257.50 | ' | 1,257.50 | ' | ' | 1,108.70 |
Current portion of long-term debt | 3.3 | ' | 3.3 | ' | ' | 4.2 |
Accounts payable | 63.5 | ' | 63.5 | ' | ' | 16.1 |
Other current liabilities | 44.9 | ' | 44.9 | ' | ' | 47.1 |
Total current liabilities | 111.7 | ' | 111.7 | ' | ' | 67.4 |
Long-term debt, less current portion | 252.2 | ' | 252.2 | ' | ' | 249.5 |
Other noncurrent liabilities | 165.4 | ' | 165.4 | ' | ' | 169.9 |
Intercompany payables | 50 | ' | 50 | ' | ' | 33.2 |
Total liabilities | 579.3 | ' | 579.3 | ' | ' | 520 |
Shareowners' (deficit) equity | 678.2 | ' | 678.2 | ' | ' | 588.7 |
Total liabilities and shareowners' equity (deficit) | 1,257.50 | ' | 1,257.50 | ' | ' | 1,108.70 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 157.3 | ' | 197.4 | ' |
Capital expenditures | ' | ' | -96.5 | ' | -116.4 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 0 | ' | ' | ' |
Dividends received from CyrusOne | ' | ' | 0 | ' | 0 | ' |
Proceeds from sale of assets | ' | ' | 2 | ' | 1.8 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | ' | -12.2 | ' |
Other investing activities | ' | ' | 0 | ' | 0.4 | ' |
Cash flows used in investing activities | ' | ' | -94.5 | ' | -126.4 | ' |
Proceeds from issuance of long-term debt | ' | ' | ' | ' | 0 | ' |
Funding between Parent and subsidiaries, net | ' | ' | -64.3 | ' | -32.9 | ' |
Debt issuance costs | ' | ' | ' | ' | 0 | ' |
Borrowings on revolving facilities, net | ' | ' | 6.2 | ' | -52 | ' |
Repayment of debt | ' | ' | -5.2 | ' | -3.5 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | ' | 0 | ' |
Other financing activities | ' | ' | 0.3 | ' | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -63 | ' | -88.4 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | -0.2 | ' | -17.4 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 2.2 | 2.2 | 19.5 | ' |
Cash and cash equivalents at end of period | 2 | 2.1 | 2 | ' | 2.1 | ' |
Notes guaranteed by subsidiaries [Member] | Consolidation, Eliminations [Member] | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' | ' |
Revenue | -13.2 | -14.1 | -42 | ' | -42.2 | ' |
Operating costs and expenses | -13.2 | -14.1 | -42 | ' | -42.2 | ' |
Operating income (loss) | 0 | 0 | 0 | ' | 0 | ' |
Interest expense (income), net | 0 | 0 | 0 | ' | 0 | ' |
Other (income) expense, net | 0 | 0 | 0 | ' | 0 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | 0 | 0 | 0 | ' | 0 | ' |
Income tax expense (benefit) | 0 | 0 | 0 | ' | 0 | ' |
Equity in earnings of subsidiaries, net of tax | -11.2 | -34.8 | -195.1 | ' | -89.4 | ' |
Net (loss) income | -11.2 | -34.8 | -195.1 | ' | -89.4 | ' |
Other comprehensive income (loss) | 0 | 0 | 0 | ' | 0 | ' |
Total comprehensive (loss) income | -11.2 | -34.8 | -195.1 | ' | -89.4 | ' |
Preferred stock dividends | 0 | 0 | 0 | ' | 0 | ' |
Net (loss) income applicable to common shareowners | -11.2 | -34.8 | -195.1 | ' | -89.4 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 0 | 0 | 0 | ' | 0 | ' |
Receivables, net | 0 | ' | 0 | ' | ' | 0 |
Other current assets | -0.7 | ' | -0.7 | ' | ' | -0.7 |
Total current assets | -0.7 | ' | -0.7 | ' | ' | -0.7 |
Property, plant and equipment, net | 0 | ' | 0 | ' | ' | 0 |
Investment in CyrusOne | 0 | ' | 0 | ' | ' | 0 |
Goodwill and intangibles, net | 0 | ' | 0 | ' | ' | 0 |
Investments in and advances to subsidiaries | -1,745.90 | ' | -1,745.90 | ' | ' | -1,623.20 |
Other noncurrent assets | -156.1 | ' | -156.1 | ' | ' | -167.8 |
Total assets | -1,902.70 | ' | -1,902.70 | ' | ' | -1,791.70 |
Current portion of long-term debt | 0 | ' | 0 | ' | ' | 0 |
Accounts payable | 0 | ' | 0 | ' | ' | 0 |
Other current liabilities | 0.1 | ' | 0.1 | ' | ' | 0.1 |
Total current liabilities | 0.1 | ' | 0.1 | ' | ' | 0.1 |
Long-term debt, less current portion | 0 | ' | 0 | ' | ' | 0 |
Other noncurrent liabilities | -156.9 | ' | -156.9 | ' | ' | -168.6 |
Intercompany payables | -362.3 | ' | -362.3 | ' | ' | -429.5 |
Total liabilities | -519.1 | ' | -519.1 | ' | ' | -598 |
Shareowners' (deficit) equity | -1,383.60 | ' | -1,383.60 | ' | ' | -1,193.70 |
Total liabilities and shareowners' equity (deficit) | -1,902.70 | ' | -1,902.70 | ' | ' | -1,791.70 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 0 | ' | 0 | ' |
Capital expenditures | ' | ' | 0 | ' | 0 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 0 | ' | ' | ' |
Dividends received from CyrusOne | ' | ' | 0 | ' | 0 | ' |
Proceeds from sale of assets | ' | ' | 0 | ' | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | ' | 0 | ' |
Other investing activities | ' | ' | 0 | ' | 0 | ' |
Cash flows used in investing activities | ' | ' | 0 | ' | 0 | ' |
Proceeds from issuance of long-term debt | ' | ' | ' | ' | 0 | ' |
Funding between Parent and subsidiaries, net | ' | ' | 0 | ' | 0 | ' |
Debt issuance costs | ' | ' | ' | ' | 0 | ' |
Borrowings on revolving facilities, net | ' | ' | 0 | ' | 0 | ' |
Repayment of debt | ' | ' | 0 | ' | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | ' | 0 | ' |
Other financing activities | ' | ' | 0 | ' | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | 0 | ' | 0 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 0 | ' | 0 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 0 | 0 | 0 | ' |
Cash and cash equivalents at end of period | $0 | $0 | $0 | ' | $0 | ' |